RARE
Ultragenyx
14.80$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +102.3% | +147.4% | +70.1% | +235.4% | -56.3% | +43.6% | +8.0% | +37.6% | +42.7% | +36.7% | -1.5% | |
| – | +361.3% | +94.1% | +40.8% | +17.8% | +2.4% | +4.6% | +22.4% | +24.2% | +3.7% | +16.9% | -3.2% | |
| – | +250.1% | +80.8% | +13.6% | -235.7% | – | -98.9% | -75.2% | +31,731.1% | – | – | – | |
| – | +257.2% | +240.0% | -176.9% | – | – | – | -160.4% | – | -125.1% | – | -265.3% | |
| – | +130.6% | +105.6% | -72.6% | +45.9% | +509.2% | +76.8% | +66.5% | +99.9% | -68.0% | -84.0% | -19.9% | |
| – | +136.8% | – | -37.3% | -159.1% | -60.9% | +1,273.7% | +9.1% | +49.3% | – | -110.6% | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +147.0% | -81.3% | +61.7% | +111.6% | +13.9% | +54.3% | -92.4% | -73.0% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | +152.8% | -70.3% | -1.7% | +147.2% | +101.7% | -11.6% | -80.3% | +322.8% | -22.6% | +2.9% | +19.7% | |
| – | +309.8% | -2.4% | -189.8% | – | +2,469.0% | -9.6% | -243.7% | – | – | -143.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.